FDA panel split on approach to COVID-19 vaccines for younger children
Regulatory NewsMichael Mezher • Joanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsHealth Authority meeting and communication strategyNorth AmericaResearch, Design and Development